Teva, Mylan Reach Deal Ending MS Drug Litigation In Europe
Mylan Inc. and Teva Pharmaceutical Industries Ltd. announced Monday that they have reached a confidential agreement to settle patent litigation over Teva's multiple sclerosis drug Copaxone in three European courts....To view the full article, register now.
Already a subscriber? Click here to view full article